| Dr Manfred Paul Mueller, MD | |
|
701 E County Line Road, Suite 101, Greenwood, IN 46143-1070 | |
| (317) 885-2860 | |
| (317) 885-2869 |
| Full Name | Dr Manfred Paul Mueller |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 42 Years |
| Location | 701 E County Line Road, Greenwood, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174503650 | NPI | - | NPPES |
| 100421010 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RS0012X | Internal Medicine - Sleep Medicine | 01036623A (Indiana) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 01036623 (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan Health Indianapolis | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana Internal Medicine Consultants Llc | 7911899489 | 41 |
| St Francis Medical Group Llc | 7012067697 | 112 |
News Archive
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.
GI Partners ("GI"), a leading mid-market private equity firm, announced today the sale of its portfolio company, Plum Healthcare Group, LLC ("Plum"), one of the fastest growing companies in healthcare services, to Bay Bridge Capital Partners ("Bay Bridge"). The sale of Plum generated a return of approximately three times invested capital for limited partners in GI Partners Fund II L.P.
The Scripps Research Institute has been awarded a $1.3 million grant by the National Institutes of Health (NIH) to develop a series of tests at its Florida campus to help explore the potential of a protein that has emerged as a highly attractive target for the treatment of obesity and Type 2 diabetes.
VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI), a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today an agreement with its subsidiary Secure eHealth to market DRM Security's Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare markets.
› Verified 8 days ago
| Entity Name | Indiana Internal Medicine Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609834357 PECOS PAC ID: 7911899489 Enrollment ID: O20040329000685 |
News Archive
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.
GI Partners ("GI"), a leading mid-market private equity firm, announced today the sale of its portfolio company, Plum Healthcare Group, LLC ("Plum"), one of the fastest growing companies in healthcare services, to Bay Bridge Capital Partners ("Bay Bridge"). The sale of Plum generated a return of approximately three times invested capital for limited partners in GI Partners Fund II L.P.
The Scripps Research Institute has been awarded a $1.3 million grant by the National Institutes of Health (NIH) to develop a series of tests at its Florida campus to help explore the potential of a protein that has emerged as a highly attractive target for the treatment of obesity and Type 2 diabetes.
VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI), a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today an agreement with its subsidiary Secure eHealth to market DRM Security's Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare markets.
› Verified 8 days ago
| Entity Name | St Francis Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467693135 PECOS PAC ID: 7012067697 Enrollment ID: O20090603000310 |
News Archive
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.
GI Partners ("GI"), a leading mid-market private equity firm, announced today the sale of its portfolio company, Plum Healthcare Group, LLC ("Plum"), one of the fastest growing companies in healthcare services, to Bay Bridge Capital Partners ("Bay Bridge"). The sale of Plum generated a return of approximately three times invested capital for limited partners in GI Partners Fund II L.P.
The Scripps Research Institute has been awarded a $1.3 million grant by the National Institutes of Health (NIH) to develop a series of tests at its Florida campus to help explore the potential of a protein that has emerged as a highly attractive target for the treatment of obesity and Type 2 diabetes.
VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI), a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today an agreement with its subsidiary Secure eHealth to market DRM Security's Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare markets.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manfred Paul Mueller, MD 701 E County Line Road, Suite 101, Greenwood, IN 46143-1070 Ph: (317) 885-2860 | Dr Manfred Paul Mueller, MD 701 E County Line Road, Suite 101, Greenwood, IN 46143-1070 Ph: (317) 885-2860 |
News Archive
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced the presentation of positive final data, including survival data, from the Company's Phase 2 clinical trial of picoplatin as a first-line therapy in men with metastatic castration-resistant (hormone-refractory) prostate cancer (CRPC). The results were presented in a General Poster Session today at the 2010 American Society of Clinical Oncology's Genitourinary Cancers Symposium in San Francisco, CA.
There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.
GI Partners ("GI"), a leading mid-market private equity firm, announced today the sale of its portfolio company, Plum Healthcare Group, LLC ("Plum"), one of the fastest growing companies in healthcare services, to Bay Bridge Capital Partners ("Bay Bridge"). The sale of Plum generated a return of approximately three times invested capital for limited partners in GI Partners Fund II L.P.
The Scripps Research Institute has been awarded a $1.3 million grant by the National Institutes of Health (NIH) to develop a series of tests at its Florida campus to help explore the potential of a protein that has emerged as a highly attractive target for the treatment of obesity and Type 2 diabetes.
VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI), a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today an agreement with its subsidiary Secure eHealth to market DRM Security's Secure Document Courier and Storage technology (Cifra(TM)) to the healthcare markets.
› Verified 8 days ago
Dr. Michael B Dubois, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2860 Fax: 317-885-2869 | |
Dr. Cary Zietlow, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 45 N Madison Ave, Greenwood, IN 46142 Phone: 317-887-7624 Fax: 317-887-7625 | |
Dr. Abhinav Singh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2860 Fax: 317-885-2869 | |
Dr. John Robert Colaluca, D.O Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 898 E Main St, Greenwood, IN 46143 Phone: 317-887-1348 Fax: 317-882-1631 | |
Edris Ayoubi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2860 Fax: 317-885-2869 | |
Walid Samaan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1040 Sierra Dr, Suite 400, Greenwood, IN 46143 Phone: 317-528-4270 Fax: 317-865-8336 | |
Dr. Ruxandra C Ionescu, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 701 E County Line Rd, Suite 101, Greenwood, IN 46143 Phone: 317-885-2334 Fax: 317-885-2869 |